Glioma Clinical Trials
Glioma clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for glioma. Corterve aggregates actively recruiting Glioma studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Glioma studies
- Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)NCT04924075PHASE2Merck Sharp & Dohme LLCPheochromocytoma/ParagangliomaLos Angeles, California
- NeuroPathways Intervention for Brain Tumor PatientsNCT05976490NAMassachusetts General HospitalMalignant Brain TumorBoston, Massachusetts
- A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)NCT05099003PHASE1, PHASE2National Cancer Institute (NCI)Malignant GliomaBirmingham, Alabama
- Supportive Psychoeducational Intervention for Patients With Brain Tumors (Acceptance and Commitment Therapy-based Supportive Intervention for Patients With Central Nervous System Tumors)NCT06099743NAMassachusetts General HospitalMalignant Brain TumorBoston, Massachusetts
- [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck CancersNCT06479811PHASE1National Cancer Institute (NCI)Sinonasal Neuroendocrine CarcinomaBethesda, Maryland
- Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIIINCT07326566PHASE2Black Diamond Therapeutics, Inc.Glioblastoma (GBM)Birmingham, Alabama
- Blood-Brain Barrier Disruption Using Exablate Magnetic Resonance-Guided Low Intensity Focused Ultrasound With Microbubbles in Combination With T-Cell Infusion in Patients With Newly Diagnosed Diffuse Midline Glioma (LIFT)NCT07796061PHASE1Children's National Research InstitutePontine Diffuse Midline GliomaWashington D.C., District of Columbia
- A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3NCT05916313PHASE1Boehringer IngelheimGliomaOrange, California
- Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and ParagangliomaNCT07282587PHASE2Jazz PharmaceuticalsAdvanced Pheochromocytoma and ParagangliomaLos Angeles, California
- Dabrafenib and/or Trametinib Rollover StudyNCT03340506PHASE4Novartis PharmaceuticalsMelanomaScottsdale, Arizona
- Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual DiseaseNCT07025226EARLY_PHASE1Mayo ClinicGliomaRochester, Minnesota
- MCT for the Harvard/UCSF ROBIN CenterNCT06000787NABrigham and Women's HospitalGlioma, Childhood BrainstemSan Francisco, California
Glioma trials by state
Glioma trials by metro
Frequently asked questions
- How do I find recruiting Glioma clinical trials?
- Browse the actively recruiting Glioma studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Glioma clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Glioma clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.